OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Ther

Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibody industry thought leaders and research scientists from around the worldEMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (Nasdaq: OABI) announces the presentation of new scientific data on...

Related Keywords

United States ,Emeryville ,California ,San Diego ,Neha Singh ,Diego Marina ,Matt Foehr ,Bob Chen ,Christine Vuong ,Company Biological Intelligence ,Antibody Society ,Omniab Inc ,Nasdaq ,Company Omnichicken ,Therapeutics Conference ,Senior Scientist ,Robust Immune Repertoires ,High Affinity Binding ,Chief Executive Officer ,Bill Harriman ,Senior Vice President ,Antibody Discovery ,Marriott Marquis San Diego ,Diverse Omniab Antibody Repertoires ,Senior Director ,Discovery Systems ,Private Securities Litigation Reform Act ,